510(k) · Cleared
Recalled · Class II · 2012Ace Urea Nitrogen Reagent, Calcium-Arseazo Reagent, Creatinine Reagent, Inorganic Phosphorus U.V. Reagent,Urine Standard
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Alfa Wassermann Diagnostic Technologies, Inc. · CDN Urease, Photometric, Urea Nitrogen
Cleared on Sep 8, 2011 as substantially equivalent to K954000 (Roche Diagnostic Systems, Inc., 1995) and 4 other predicates after a 273-day review. Its family tree reaches back 1 generation to 1988. It has been recalled once.
- Decided
- Sep 8, 2011
- Review
- 273 days
- Class
- Class II
- Product code
- CDN
- Recalls
- 1
- Predicates
- 5
Its longest line of descent runs back 1 generation to K875285 (1988). 5 ancestors in all. No later device cites it as a predicate yet.
- Root · 1 generation backK875285 Multi-Chemistry Linearity StandardVerichem Laboratories, Inc. · 1988
- This deviceK103615 Ace Urea Nitrogen Reagent, Calcium-Arseazo Reagent, Creatinine…Alfa Wassermann Diagnostic Technologies, Inc. · 2011
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K875285 | Multi-Chemistry Linearity Standard | Verichem Laboratories, Inc. | 1988 | — |
| 0 (this device) | K103615 | Ace Urea Nitrogen Reagent, Calcium-Arseazo Reagent, Creatinine Reagent… | Alfa Wassermann Diagnostic Technologies, Inc. | 2011 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1988 | 1 | 0 |
| 1990 | 2 | 0 |
| 1995 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in CDN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (5)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K954000 | Roche Reagent for BunSummary page 2…Roche Diagnostics COBAS INTEGRA reagents: Reagent 510(k)# Urea/BUN K954000 Calcium K896224 Phosphate (Inorganic) ver.2 K… | 1995 |
| * | K896224 | Cobas Ready Calcium ReagentSummary page 2…Reagent 510(k)# Urea/BUN K954000 Calcium K896224 Phosphate (Inorganic) ver.2 K883962 Siemens Healthcare Diagnostics AD… | 1990 |
| * | K883962 | Roche Reagent for Inorganic PhosphorusSummary page 2…Urea/BUN K954000 Calcium K896224 Phosphate (Inorganic) ver.2 K883962 Siemens Healthcare Diagnostics ADVIA 1800/2400 reagent: Reagent… | 1988 |
| * | K901229 | Chem 1 Clinical Analyzer (Method Urine Creatinine)Summary page 2…lthcare Diagnostics ADVIA 1800/2400 reagent: Reagent 510(k)#t Creatinine (CRE-2c) K90 1229 Verichemn Laboratories, Inc. standard: Reagent 5… | 1990 |
| * | K875285 | Multi-Chemistry Linearity StandardSummary page 2…Verichemn Laboratories, Inc. standard: Reagent 510(k)# Urine Chemistry Standard K875285 Device In the ACE Urea Nitrogen Reagent assay, urea in urine is hydrolyzed to Descriptions: yiel… | 1988 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
Recalls of this device
| Date | Class | Recall | Root cause | Reason |
|---|---|---|---|---|
| Oct 10, 2012 | Class II | Z-0743-2013 | Device Design | Inorganic phosphorus assays using System Diluent Lot 155599 may not product acceptable calibration results. |
No ancestor or descendant has a Class I recall.
What does this lineage say?
- None of the 5 ancestors has a recall.
- 3 other devices also cite its predicate K954000.
How does its category compare?
All CDN devicesCDN Urease, Photometric, Urea Nitrogen: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.
FDA decisions per year · CDN
1in 2019
2026 to Oct 25, outlined.
Median 510(k) review, days · CDN
Too few CDN 510(k)s in any year since 2007 to give a median.
Recalls per year · CDN
1in 2013
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · CDN
2in 2015
MAUDE reports naming product code CDN, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 1 | — | 0 | 0 |
| 2012 | 1 | — | 0 | 0 |
| 2013 | 2 | — | 1 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 2 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 1 | — | 0 | 0 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 0 |
| 2024 | 0 | — | 0 | 0 |
| 2025 | 0 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The ACE Urea Nitrogen Reagent is intended for the quantitative determination of urea nitrogen concentration in urine using the ACE and ACE Alera Clinical Chemistry Systems. Urea nitrogen measurements are used in the diagnosis and treatment of certain renal and metabolic diseases. This test is intended for use in clinical laboratories or physician office laboratories. For in vitro diagnostic use only. The ACE Calcium-Arsenazo Reagent is intended for the…
Read the full statement (292 words)
The ACE Urea Nitrogen Reagent is intended for the quantitative
determination of urea nitrogen concentration in urine using the
ACE and ACE Alera Clinical Chemistry Systems. Urea nitrogen
measurements are used in the diagnosis and treatment of certain
renal and metabolic diseases. This test is intended for use in
clinical laboratories or physician office laboratories. For in vitro
diagnostic use only.
The ACE Calcium-Arsenazo Reagent is intended for the
quantitative determination of calcium in urine using the ACE and
ACE Alera Clinical Chemistry Systems. Calcium measurements
are used in the diagnosis and treatment of parathyroid disease, a
variety of bone diseases, chronic renal disease and tetany. This test
is intended for use in clinical laboratories or physician office
laboratories. For in vitro diagnostic use only.
The ACE Creatinine Reagent is intended for the quantitative
determination of creatinine in urine using the ACE and ACE Alera
Clinical Chemistry Systems. Creatinine measurements are used in
the diagnosis and treatment of renal diseases, in monitoring renal
dialysis and as a calculation basis for measuring other urine
analytes. This test is intended for use in clinical laboratories or
physician office laboratories. For in vitro diagnostic use only.
The ACE Inorganic Phosphorus U.V. Reagent is intended for the
quantitative determination of inorganic phosphorus concentration
in urine using the ACE and ACE Alera Clinical Chemistry
Systems. Measurements of inorganic phosphorus are used in the
diagnosis and treatment of various disorders, including parathyroid
gland and kidney diseases and vitamin D imbalance. This test is
intended for use in clinical laboratories or physician office
laboratories. For in vitro diagnostic use only.
Alfa Wassermann Diagnostic Technologies, LLC ACE Urine
Standard is intended for the calibration of quantitative urine
reagents on Alfa Wassermann Clinical Chemistry Systems. For in
vitro diagnostic use only.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K103615 · printed Nov 6, 2026
Cite this page
510(k) Report. “K103615: Ace Urea Nitrogen Reagent, Calcium-Arseazo Reagent, Creatinine Reagent, Inorganic Phosphorus U.V. Reagent,Urine Standard.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K103615
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026